Skip to main content

Fibrinogen-specific T cells in rheumatoid arthritis

Rheumatoid arthritis (RA) is characterized by the occurence of autoreactive antibodies and T cells. The family of antibodies directed to citrulline-containing antigens (anti-filaggrin, anti-CCP and anti-Sa) have the highest specificity (>98%) for RA. To investigate the presence of citrulline-specific T cells in RA patients, we analyzed T-cell reactivity to unmodified and citrullinated filaggrin and fibrinogen in modified T-cell proliferation assays. No T-cell responses were observed when either unmodified or citrullinated filaggrin was used as the stimulating antigen in serum-free T-cell proliferation assays. With unmodified fibrinogen, however, T-cell proliferation was observed in 8/15 (53%) of RA patients, while only 1/14 control patients (SLE, SSc, PsoA, Sjö) displayed clearly positive T-cell proliferation. The difference was highly significant (P < 0.0001). These findings were even more pronounced when using citrullinated fibrinogen as stimulating antigen: 10/15 (67%) RA patients were positive for T-cell proliferation and again only 1/14 control patients was clearly positive (P < 0.0001). T-cell reactivity in RA patients was significantly (P < 0.05) higher against citrullinated as compared with unmodified fibrinogen.

We conclude that fibrinogen (citrullinated or not) can induce proliferation of RA T cells, thereby further substantiating its pathogenic relevance.

Author information

Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Vossenaar, E., Bergholz, R., Schumann, F. et al. Fibrinogen-specific T cells in rheumatoid arthritis. Arthritis Res Ther 5, 31 (2003). https://doi.org/10.1186/ar661

Download citation

Keywords

  • Public Health
  • Rheumatoid Arthritis
  • Arthritis
  • Rheumatoid Arthritis Patient
  • Fibrinogen